Research ArticleMetabolism, Transport, and Pharmacogenomics
Differential interaction of dantrolene, glafenine, nalidixic acid, and prazosin with human organic anion transporters 1 and 3 (OAT1; OAT3)
Birgitta C Burckhardt, Maja Henjakovic, Yohannes Hagos and Gerhard Burckhardt
Journal of Pharmacology and Experimental Therapeutics June 19, 2017, jpet.117.241406; DOI: https://doi.org/10.1124/jpet.117.241406
Birgitta C Burckhardt
1 University Medical Center Gottingen;
Maja Henjakovic
2 Department I of Internal Medicine, University Medical Center Cologne;
Yohannes Hagos
3 PortaCellTec Biosciences GmbH
Gerhard Burckhardt
1 University Medical Center Gottingen;
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleMetabolism, Transport, and Pharmacogenomics
Differential interaction of dantrolene, glafenine, nalidixic acid, and prazosin with human organic anion transporters 1 and 3 (OAT1; OAT3)
Birgitta C Burckhardt, Maja Henjakovic, Yohannes Hagos and Gerhard Burckhardt
Journal of Pharmacology and Experimental Therapeutics June 19, 2017, jpet.117.241406; DOI: https://doi.org/10.1124/jpet.117.241406
Research ArticleMetabolism, Transport, and Pharmacogenomics
Differential interaction of dantrolene, glafenine, nalidixic acid, and prazosin with human organic anion transporters 1 and 3 (OAT1; OAT3)
Birgitta C Burckhardt, Maja Henjakovic, Yohannes Hagos and Gerhard Burckhardt
Journal of Pharmacology and Experimental Therapeutics June 19, 2017, jpet.117.241406; DOI: https://doi.org/10.1124/jpet.117.241406
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement